Post-earnings recap
Reported
Thu, Feb 23, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported a loss per share that was significantly below expectations, indicating potential challenges in their operations. Despite this, the stock saw a slight increase of 0.17%, suggesting that investors may be looking past the short-term results. The lack of guidance may lead to uncertainty among investors about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.70 | N/A | -170.35% |
Management expressed concern over current market conditions but remains focused on future opportunities. They did not provide specific guidance for upcoming quarters.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.